[ Price : $8.95]
Eli Lilly says its investigational weight-loss pill met most criteria for FDAs new national priority voucher program and could be ...[ Price : $8.95]
Johnson & Johnson files a supplemental BLA seeking to expand the use of its biologic therapy Stelara (ustekinumab) to treat childr...[ Price : $8.95]
CBER director Vinay Prasad says FDA is preparing to introduce a new, accelerated pathway for approving custom gene-editing therapi...[ Price : $8.95]
FDA announces new actions aimed at protecting children from unapproved ingestible fluoride prescription drugs.[ Price : $8.95]
A Friends of Cancer Research working group suggests ways to overcome challenges in selecting standard of care comparators for onco...[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Zydus drug manufacturing facility in Baddi, India.[ Price : $8.95]
FDA issues a clinical hold on Intellia Therapeutics MAGNITUDE and MAGNITUDE-2 Phase 3 trials for nexiguran ziclumeran after the co...[ Price : $8.95]
FDA clears a Tosoh Bioscience 510(k) for its next-generation Automated Glycohemoglobin Analyzer for rapid HbA1c (blood sugar) test...